Weight-based combination therapy with peginterferon alpha-2b and ribavirin for Naïve, relapser and non-responder patients with chronic hepatitis C

Weight-based combination therapy with peginterferon alpha-2b and ribavirin for Naïve, relapser and non-responder patients with chronic hepatitis C

Combination therapy with pegylated interferon and ribavirin is considered the new standard therapy for naïve patients with chronic hepatitis C. We evaluated the efficacy and safety of treatment with weight-based peginterferon alpha-2b (1.5 mg/kg per week) plus ribavirin (800-1,200 mg/day) for 48 wee...

Full description

Bibliographic Details
Main Authors: Fernando Lopes Gonçales Jr., Aline Vigani, Neiva Gonçales, Antonio Alci Barone, Evaldo Araújo, Roberto Focaccia, Umbeliana Oliveira, Henrique Sérgio Morais Coelho, Jacqueline Paixao, Renata Perez, Cirley Lobato, Judith Weirich, Heitor Rosa, Andrelina Borges, Ricardo Vila, Maria Lúcia Corrêa-Giannella, Maria Lúcia Gomes Ferraz
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Hepatitis C
interferon alpha-2b
therapy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000500002&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000500002&lng=en&tlng=en

Similar Items